Comparing two amiodarone doses after heart shock treatment for atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had atrial fibrillation that lasted at least 7 days.
- You are scheduled for an electrical cardioversion (a procedure to 'shock' your heart back into normal rhythm).
- You are not allergic to amiodarone or have had serious side effects from it before.
- You have a smartphone and know how to use it.
- You have normal thyroid function and no severe liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
This study compares three different daily doses of the heart rhythm medication amiodarone to find the most effective one for preventing episodes of paroxysmal atrial fibrillation. Participants will take one of three doses (100, 200, or 400 mg) for up to 12 months, and the study will monitor how well each dose controls the irregular heartbeat.
This study tests whether giving a short course of a medication called amiodarone after heart surgery helps prevent or control new irregular heartbeats (atrial fibrillation) and helps you leave the hospital sooner.
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This trial tests whether giving the drug amiodarone early can prevent dangerous heart rhythm problems in patients who survived a cardiac arrest with a shockable rhythm. If it works, it could help more people recover.
This trial tests whether a procedure called electrical cardioversion (a controlled shock to reset your heart rhythm) can help explain and possibly improve symptoms of atrial fibrillation and heart failure. If you qualify, you'll receive this procedure and your symptoms will be closely monitored.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.